Peyronie’s Disease

Summary of “Improved Peyronie’s Disease Curvature Outcomes Using a Novel Collagenase Administration Protocol”

Summary of “Improved Peyronie’s Disease Curvature Outcomes Using a Novel Collagenase Administration Protocol” Collagenase Clostridium Histolyticum (CCH) can be used on men with Peyronie’s Disease (PD) to improve penile curvature. Since the release of CCH in 2014 studies have consistently shown penile curvature improvements in men with PD in the 14-23˚ range (similar to findings […]

Summary of “Improved Peyronie’s Disease Curvature Outcomes Using a Novel Collagenase Administration Protocol” Read More »

Summary of “Predictors of Curvature Improvement in Men With Peyronie’s Disease Treated With Intralesional Collagenase Clostridium Histolyticum”

The following is a summary of an article recently published in the Journal of Sexual Medicine.  We provide these summaries in the hopes that they will help patients keep up to date on the latest research published on the topics of PD and male infertility.  This particular study’s goal was to define the factors that

Summary of “Predictors of Curvature Improvement in Men With Peyronie’s Disease Treated With Intralesional Collagenase Clostridium Histolyticum” Read More »

What Causes Peyronie’s Disease?

What is Peyronie’s disease? Peyronie’s disease (PD) is a connective tissue disorder affecting the tunica albuginea and is characterized by penile curvature resulting from fibrosis and plaque deposits.  PD can not only cause physical pain, but it can also cause psychological and psychosexual issues.  PD affects between 0.4 to 20+% of the male population (depending

What Causes Peyronie’s Disease? Read More »

Summary of “Cost of Intralesional Collagenase Clostridium Histolyticum Therapy Versus Surgery for the Management of Peyronie’s Disease: A Claims-Based Analysis (2009-2019)”

Peyronie’s Disease (PD) is a fibrotic disorder of the tunica albuginea of the corpora cavernosa and is progressive in nature. Consequently, this disorder is linked to a decrease in sexual performance and self-confidence. Currently, treatments include oral medication, surgical reconstruction, and injectable therapy. The purpose of this study was to compare the costs of treatment

Summary of “Cost of Intralesional Collagenase Clostridium Histolyticum Therapy Versus Surgery for the Management of Peyronie’s Disease: A Claims-Based Analysis (2009-2019)” Read More »

Summary of “The use of a polyglycolic acid polymer graft in Peyronie’s disease – preliminary outcomes”

Peyronie’s Disease (PD) is a connective tissue disorder of the penis affecting the tunica albuginea. This disorder can lead to penile deformity and local pain. No one knows what causes PD; however, it is thought that PD could be caused by repetitive microvascular trauma, causing inflammation, excessive collagen deposition, and fibrinogenesis on the tunica albuginea.

Summary of “The use of a polyglycolic acid polymer graft in Peyronie’s disease – preliminary outcomes” Read More »

Summary of “Modern treatment strategies for penile prosthetics in Peyronie’s disease: a contemporary clinical review”

***Trost Commentary and Key Take-Home Points*** The current manuscript is a review article (summarizes research publications performed by other teams) which discusses the role of penile prosthetics in men with Peyronie’s Disease.  Penile prosthetics have a clear role for the treatment of PD men who have erectile dysfunction which does not respond to PDE5 inhibitors (i.e. Viagra, Levitra,

Summary of “Modern treatment strategies for penile prosthetics in Peyronie’s disease: a contemporary clinical review” Read More »

Summary of “What role do pharmaceuticals play in the treatment of Peyronie’s disease and is there a need for new emerging drugs?”

***Trost Commentary and Key Take-Home Points*** This is a great commentary which highlights the significant need that we have for better medications to treat Peyronie’s Disease.  For decades, dozens of medicines, herbals, topicals, and energy types of treatments have been used to try to treat Peyronie’s Disease.  And, with few exceptions, none of them have showed any true promise in

Summary of “What role do pharmaceuticals play in the treatment of Peyronie’s disease and is there a need for new emerging drugs?” Read More »

Summary of “Intralesional Injection of Hyaluronic Acid in Patients Affected With Peyronie’s Disease: Preliminary Results From a Prospective, Multicenter, Pilot Study”

***Trost Commentary and Key Take-Home Points*** The current study evaluates the use of intralesional hyaluronic acid to treat Peyronie’s Disease.  This is one of 4 different types of injections which are most commonly reported, with the others being collagenase (Xiaflex), interferon, and verapamil.  This specific injection is more commonly used in Europe, particularly now that collagenase is no

Summary of “Intralesional Injection of Hyaluronic Acid in Patients Affected With Peyronie’s Disease: Preliminary Results From a Prospective, Multicenter, Pilot Study” Read More »

Summary of “OUTCOMES OF A NOVEL PENILE TRACTION DEVICE (RESTOREX) IN MEN WITH PEYRONIE’S DISEASE: A RANDOMIZED, SINGLE-BLINDED, CONTROLLED TRIAL”

***Trost Commentary and Key Take-Home Points*** This study was one that we conducted soon after RestoreX became available.  Our goal was to determine if the device resulted in any benefits or not in treating Peyronie’s Disease.  My experience with traction devices to that point had not been very good.  Specifically, we had previously performed a study where we evaluated whether

Summary of “OUTCOMES OF A NOVEL PENILE TRACTION DEVICE (RESTOREX) IN MEN WITH PEYRONIE’S DISEASE: A RANDOMIZED, SINGLE-BLINDED, CONTROLLED TRIAL” Read More »

Scroll to Top